Activation of glycogenolysis and glycolysis in breast cancer stem cell models

Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165886. doi: 10.1016/j.bbadis.2020.165886. Epub 2020 Jun 24.

¹ Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
² Biosfer Teslab SL, Reus, Tarragona, Spain.
³ Universitat Rovira i Virgili, Department of Electronic Engineering, IISPV, Tarragona 43007; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid 28029, Spain.
⁴ Central European Institute of Technology (CEITEC), Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.
⁵ Central European Institute of Technology (CEITEC), Masaryk University, Kamenice 5, 62500 Brno, Czech Republic; National Centre for Biomolecular Research, Faculty of Science, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.
⁶ Institute of Molecular Biology and Biophysics, Federal Research Center of Fundamental and Translational Medicine, 630117 Novosibirsk, Russia; Vall D'Hebron Institut de Recerca, 08035 Barcelona, Spain.. Electronic address: alex.lyakhovich@mail.muni.

No abstract available

Keywords: Breast cancer; Cancer stem cell; Glycogenolysis; Glycolysis; HIF1a; Metabolic reprogramming.

Publication types